Danaher Corporation ($DHR) Stock Forecast: Down 9.9% Today

What is Danaher Corporation?

Danaher Corporation (DHR) is a global science and technology innovator known for its diverse range of products and services in the healthcare, environmental, and industrial sectors. Today, the stock experienced a significant bearish movement in the market.

Why is Danaher Corporation going down?

DHR stock is down 9.9% on Jan 29, 2025 18:06

• Danaher's Q4 earnings missed estimates, with a negative surprise on both earnings and revenue, indicating potential challenges in the company's financial performance.
• The decline in the diagnostics segment impacted overall earnings performance, highlighting a specific area of weakness within the company.
• The unusual options activity showing a bearish stance on Danaher suggests that investors with significant capital are taking a pessimistic view on the stock, potentially contributing to the downward pressure on its price.
• Overall, the combination of earnings miss, segment lag, and bearish sentiment from investors likely led to the bearish movement in Danaher's stock today.

DHR Price Chart

DHR Technical Analysis

DHR News

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.

https://www.zacks.com/stock/news/2405945/danaher-q4-earnings-miss-estimates-life-sciences-sales-rise-yy

Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - American Axle & Mfg Hldgs ( NYSE:AXL ) , Avnet ( NASDAQ:AVT )

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.4% on Wednesday. Shares of Manhattan Associates, Inc. MANH fell sharply in today's pre-market trading following soft FY25 guidance.

https://www.benzinga.com/25/01/43302313/manhattan-associates-lendingclub-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Danaher ( DHR ) Lags Q4 Earnings Estimates

Danaher (DHR) delivered earnings and revenue surprises of -1.38% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2405233/danaher-dhr-lags-q4-earnings-estimates

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag - Danaher ( NYSE:DHR )

Danaher's Q4 adjusted EPS missed estimates, while sales of $6.54B exceeded forecasts, driven by biotech and life sciences growth. The diagnostics segment saw a 3% decline, impacting overall earnings performance; cash flow and margins remained solid. Get Wall Street's Hottest Chart Every Morning

https://www.benzinga.com/news/earnings/25/01/43298036/danaher-q4-eps-miss-expectations-amid-diagnostics-segment-lag

Danaher Unusual Options Activity - Danaher ( NYSE:DHR )

Investors with a lot of money to spend have taken a bearish stance on Danaher DHR. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

https://www.benzinga.com/insights/options/25/01/43276122/danaher-unusual-options-activity

Trending Today

Sonic (prev. FTM) ($S) Crypto Forecast: Up 16.7% Today

Movement ($MOVE) Crypto Forecast: Up 9.9% Today

Arbitrum ($ARB) Crypto Forecast: Up 5.1% Today

Curve DAO Token ($CRV) Crypto Forecast: Up 6.1% Today

Pepe ($PEPE) Crypto Forecast: Up 6.6% Today

Litecoin ($LTC) Crypto Forecast: Up 5.1% Today

Wormhole ($W) Crypto Forecast: Up 5.9% Today

Internet Computer ($ICP) Crypto Forecast: Up 5.0% Today

Memecoin ($MEME) Crypto Forecast: Up 5.1% Today

Maker ($MKR) Crypto Forecast: Up 19.3% Today

Danaher Corporation Price History

19.06.2024 - DHR Stock was down 5.2%

• Despite Danaher's strong performance over the past 10 years, today's bearish movement could be attributed to profit-taking by investors after a prolonged period of outperformance.
• The upcoming second-quarter earnings report may have heightened market expectations, leading to a sell-off as investors may be cautious about potential risks or uncertainties.
• Danaher opening labs to expedite diagnostic development could have raised concerns about increased expenses or potential disruptions in existing operations, impacting investor sentiment.
• The comparison with conglomerate peers like Honeywell International Inc. (HON) may have also influenced market participants to reevaluate their positions in Danaher, contributing to the bearish movement.

29.00.2025 - DHR Stock was down 8.0%

• Danaher (DHR) fell short of earnings projections for Q4, with unfavorable surprises in earnings and revenue, raising concerns about its performance.
• Manhattan Associates (MANH) provided weak FY25 guidance, which may have impacted market sentiment negatively and influenced related stocks like Danaher.
• Unusual bearish options activity on Danaher indicates that some investors have a pessimistic outlook on the stock, potentially contributing to its decline.
• The varied performance of U.S. stock futures, including some stocks experiencing declines, likely added to the downward pressure on Danaher's stock price today.

29.00.2025 - DHR Stock was down 9.9%

• Danaher's Q4 earnings missed estimates, with a negative surprise on both earnings and revenue, indicating potential challenges in the company's financial performance.
• The decline in the diagnostics segment impacted overall earnings performance, highlighting a specific area of weakness within the company.
• The unusual options activity showing a bearish stance on Danaher suggests that investors with significant capital are taking a pessimistic view on the stock, potentially contributing to the downward pressure on its price.
• Overall, the combination of earnings miss, segment lag, and bearish sentiment from investors likely led to the bearish movement in Danaher's stock today.

15.00.2025 - DHR Stock was down 0.7%

• Although Danaher has historically outperformed the market, the recent bearish movement could be due to investors capitalizing on gains following a period of growth.
• Market dynamics or industry-specific developments impacting companies in a similar vein as Danaher might be influencing the stock's downturn.
• Given the current market environment, investors could be reallocating their investments, possibly exploring other industries or asset classes, leading to a decrease in Danaher's share value.

31.09.2023 - DHR Stock was up 5.6%

• Danaher's stock had a strong bullish movement today.
• The positive coverage from analysts at StockNews.com might have contributed to the bullish market movement.
• Danaher's outperformance in the market over the past 10 years, as mentioned in an article from Benzinga, could have also boosted investor confidence.
• The acquisition of Abcam and the positive commentary on M&A prospects by Veralto, as mentioned in an article from Seeking Alpha and one from CNBC respectively, could have further fueled investor optimism.

23.03.2024 - DHR Stock was up 6.6%

• Danaher (DHR) delivered strong Q1 earnings, surpassing both EPS and revenue estimates, demonstrating robust financial performance.
• Despite a decrease in Biotechnology segment sales, the overall earnings beat contributed to the stock's bullish movement.
• The favorable earnings report likely boosted investor confidence, resulting in a rise in the stock price.
• The market's positive response to Danaher's earnings differs from JetBlue's decline, suggesting company-specific momentum rather than a broader market trend.

21.10.2023 - DHR Stock was up 5.4%

• The bullish movement of DHR's stock could be attributed to the positive news and developments surrounding the company.
• The rising adoption of rapid diagnostic products in physician office laboratories, as mentioned in an article from Kwhen Finance, indicates a potential growth opportunity for DHR in the diagnostics market.
• The increase in position by Mirae Asset Global Investments Co. Ltd., as mentioned in an article from The AM Reporter, suggests confidence in the company's prospects.
• The boost in holdings by Thompson Siegel & Walmsley LLC, as mentioned in an article from The AM Reporter, further indicates investor interest in DHR.
• Overall, the positive news and increased investor activity could have contributed to the bullish movement of DHR's stock.

23.03.2024 - DHR Stock was up 6.8%

• Danaher (DHR) posted better-than-expected Q1 earnings and revenue, exceeding estimates by a significant margin, reflecting strong financial performance and market demand for its products.
• Despite anticipating a mid-single-digit drop in non-GAAP core revenue for Q2, the company's overall performance and profitability outlook are positive, as seen in the market's enthusiastic response to the earnings exceedance.
• The market's positive reaction to Danaher's earnings beat indicates investor confidence in the company's ability to tackle challenges and leverage growth opportunities in key business segments.
• Danaher's capability to outperform earnings projections and uphold a robust financial position in a challenging economic climate highlights its resilience and strategic management choices, positioning the stock well for potential future growth.

18.06.2024 - DHR Stock was down 3.1%

• Danaher's stock saw a decline despite expectations of strong earnings from the Diagnostics and Life Sciences segment.
• The establishment of labs to hasten diagnostic development could have sparked concerns about increased expenses or possible delays in revenue generation.
• When compared to conglomerate peers like Honeywell International Inc. (HON), Danaher may have demonstrated relative underperformance, which might have contributed to a pessimistic outlook among investors.
• Some investors may be cashing in on their gains following a period of strong performance, potentially adding to the stock's downward trend.

23.06.2024 - DHR Stock was up 6.4%

• Danaher's second-quarter earnings beat expectations, leading to a surge in its stock price.
• Despite a decrease in core sales in the Biotechnology segment, the overall performance of the company was impressive.
• The positive earnings report and the company's ability to surpass analyst estimates contributed to the significant rise in Danaher's stock price.
• The increase in price target by analysts and the upbeat earnings results acted as catalysts for the bullish movement in Danaher's stock today.

23.06.2024 - DHR Stock was up 7.8%

• Danaher Corporation (DHR) saw a significant uptick in its stock price following the release of its second-quarter earnings.
• The company surpassed earnings per share (EPS) and revenue expectations for Q2 2024, demonstrating solid financial performance.
• Strong performance in Danaher's bioprocessing business and the medical testing segment contributed to the earnings beat.
• Investor confidence in Danaher's financial results and strategic positioning in key markets likely fueled the positive market sentiment.

23.06.2024 - DHR Stock was up 7.5%

• Danaher beat Q2 profit estimates, showcasing strength in its medical testing business, which likely boosted investor confidence in the company's performance.
• The company's Q2 earnings and revenues surpassed estimates, indicating solid financial health and potential growth prospects, which could have attracted more investors to the stock.
• Despite a decline in Q2 profit compared to the previous year, Danaher still managed to beat expectations, demonstrating resilience and effective cost management strategies in a challenging economic environment.
• The positive earnings report from Danaher amidst a mixed market sentiment, with some sectors lagging and specific companies facing revenue forecast challenges, could have contributed to the bullish movement in DHR stock as investors sought out stable and outperforming companies in the sector.